Electrospun fibers for microbicide drug delivery

Drug Delivery and Development of Anti-HIV Microbicides

Volumn , Issue , 2014, Pages 459-507

  Ball, Cameron ^a   Woodrow, Kim A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84974624057     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.4032/9789814463577     Document Type: Chapter

References (88)

1. El-Kamel, A., Sokar, M., Naggar, V., and Al Gamal, S. (2002). Chitosan and sodium alginate-based bioadhesive vaginal tablets, AAPS Pharm. Sci, 4, E44.
2. Li, W. Z., Zhao, N., Zhou, Y. Q., Yang, L. B., Xiao-Ning, W., Bao-Hua, H., Peng, K., and Chun-Feng, Z. (2012). Post-expansile hydrogel foam aerosol of PG-liposomes: A novel delivery system for vaginal drug delivery applications, Eur. J. Pharm. Sci., 47, 162-169.
3. Akil, A., Parniak, M. A., Dezzutti, C. S., Moncla, B. J., Cost, M. R., Li, M., and Rohan, L. C. (2011). Development and characterization of a vaginal film containing dapivirine, a non-nucleoside reverse transcriptase inhibitor (NNRTI), for prevention of HIV-1 sexual transmission, Drug. Deliv. Trans. Res., 1, 209-222.
4. Kiser, P. F., Mahalingam, A., Fabian, J., Smith, E., Damian, F. R., Peters, J. J., Katz, D. F., Elgendy, H., Clark, M. R., and Friend, D. R. (2012). Design of tenofovir-UC781 combination microbicide vaginal gels, J. Pharm. Sci., 101, 1852-1864.
5. Johnson, T. J., Clark, M. R., Albright, T. H., Nebeker, J. S., Tuitupou, A. L., Clark, J. T., Fabian, J., McCabe, R. T., Chandra, N., Doncel, G. F., Friend, D. R., and Kiser, P. F. (2012). A 90-day tenofovir reservoir intravaginal ring for mucosal HIV prophylaxis, Antimicrob. Agents Chemother., 56, 6272-6283.
6. Johnson, T. J., Gupta, K. M., Fabian, J., Albright, T. H., and Kiser, P. F. (2010). Segmented polyurethane intravaginal rings for the sustained combined delivery of antiretroviral agents dapivirine and tenofovir, Eur. J. Pharm. Sci., 39, 203-212.
7. Friend, D. R., and Doncel, G. F. (2010). Combining prevention of HIV-1, other sexually transmitted infections and unintended pregnancies:Development of dual-protection technologies, Antiviral Res., 88 Suppl 1, S47-S54.
8. Skoler-Karpoff, S., Ramjee, G., Ahmed, K., Altini, L., Plagianos, M. G., Friedland, B., Govender, S., De Kock, A., Cassim, N., Palanee, T., Dozier, G., Maguire, R., and Lahteenmaki, P. (2008). Efficacy of Carraguard for prevention of HIV infection in women in South Africa: A randomised, double-blind, placebo-controlled trial, Lancet, 372, 1977-1987.
9. Abdool Karim, Q., Abdool Karim, S. S., Frohlich, J. A., Grobler, A. C., Baxter, C., Mansoor, L. E., Kharsany, A. B., Sibeko, S., Mlisana, K. P., Omar, Z., Gengiah, T. N., Maarschalk, S., Arulappan, N., Mlotshwa, M., Morris, L., and Taylor, D. (2010). Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women, Science, 329, 1168-1174.
10. Microbicide Trials Network. Understanding the Results of VOICE. Mar 4, 2013. Available from URL: http://www.mtnstopshiv.org/node/2003 (last accessed Aug 27, 2013).
11. Huang, C., Soenen, S. J., van Gulck, E., Vanham, G., Rejman, J., Van Calenbergh, S., Vervaet, C., Coenye, T., Verstraelen, H., Temmerman, M., Demeester, J., and De Smedt, S. C. (2012). Electrospun cellulose acetate phthalate fibers for semen induced anti-HIV vaginal drug delivery, Biomaterials, 33, 962-969.
12. Ball, C., Krogstad, E., Chaowanachan, T., and Woodrow, K. A. (2012). Drug-eluting fibers for HIV-1 inhibition and contraception, PLoS One, 7, e49792.
13. Teo, W.-E., Inai, R., and Ramakrishna, S. (2011). Technological advances in electrospinning of nanofibers, Sci. Technol. Adv. Mater., 12, 013002.
14. Schiffman, J. D., and Schauer, C. L. (2008). A review: Electrospinning of biopolymer nanofibers and their applications, Polym. Rev., 48, 317-352.
15. Teo, W. E., and Ramakrishna, S. (2006). A review on electrospinning design and nanofibre assemblies. Nanotechnology, 17, R89-R106.
16. Chakraborty, S., Liao, I. C., Adler, A., and Leong, K. W. (2009). Electrohydrodynamics:A facile technique to fabricate drug delivery systems, Adv. Drug Deliv. Rev., 61, 1043-1054.
17. Yu, D. G., Zhu, L. M., Branford-White, C. J., Yang, J. H., Wang, X., Li, Y., and Qian, W. (2011). Solid dispersions in the form of electrospun coresheath nanofibers, Int. J. Nanomed., 6, 3271-3280.
18. Tomar, V., Garud, N., Kannojia, P., Garud, A., Jain, N. K., and Singh, N. (2010). Enhancement of solubility of acyclovir by solid dispersion and inclusion complexation methods, Der Pharmacia Lettre, 2, 341-352.
19. Yalkowsky, S. H. (1981). Techniques of Solubilization of Drugs (Dekker, New York, NY, USA).
20. Schader, S. M., Colby-Germinario, S. P., Schachter, J. R., Xu, H., and Wainberg, M. A. (2011). Synergy against drug-resistant HIV-1 with the microbicide antiretrovirals, dapivirine and tenofovir, in combination, AIDS, 25, 1585-1594.
21. Yu, D.-G., Chian, W., Wang, X., Li, X.-Y., Li, Y., and Liao, Y.-Z. (2013). Linear drug release membrane prepared by a modified coaxial electrospinning process, J. Memb. Sci., 428, 150-156.
22. Sy, J. C., Klemm, A. S., and Shastri, V. P. (2009). Emulsion as a means of controlling electrospinning of polymers, Adv. Mater., 21, 1814-1819.
23. Macri, L. K., Sheihet, L., Singer, A. J., Kohn, J., and Clark, R. A. (2012). Ultrafast and fast bioerodible electrospun fiber mats for topical delivery of a hydrophilic peptide, J. Control. Release, 161, 813-20.
24. Magno, M. H. R., Kim, J., Srinivasan, A., McBride, S., Bolikal, D., Darr, A., Hollinger, J. O., and Kohn, J. (2010). Synthesis, degradation and biocompatibility of tyrosine-derived polycarbonate scaffolds, J. Mater. Chem., 20, 8885-8893.
25. Heller, J., Barr, J., Ng, S. Y., Abdellauoi, K. S., and Gurny, R. Poly(ortho esters): Synthesis, characterization, properties and uses, Adv. Drug Deliv. Rev., 54, 1015-1039.
26. Moghe, A., and Gupta, B. S. (2008). Co-axial electrospinning for nanofiber structures: Preparation and applications, Polym. Rev., 48, 353-377.
27. Olender, S., Wilkin, T. J., Taylor, B. S., and Hammer, S. M. (2012). Advances in antiretroviral therapy, Top. Antivir. Med., 20, 61-86.
28. Herrera, C., Cranage, M., McGowan, I., Anton, P., and Shattock, R. J. (2009). Reverse transcriptase inhibitors as potential colorectal microbicides, Antimicrob. Agents Chemother., 53, 1797-1807.
29. Heikinheimo, O., and Lähteenmäki, P. Contraception and HIV infection in women, Hum. Reprod. Update, 15, 165-176.
30. Holt, B. Y., Kilbourne-Brook, M., Stone, A., Harrison, P., and Shields, W. C. (2010). Multipurpose prevention technologies for reproductive health, Contraception, 81, 177-80.
31. Agashe, H., Hu, M., and Rohan, L. (2012). Formulation and delivery of microbicides, Curr. HIV Res., 10, 88-96.
32. Perioli, L., Ambrogi, V., Pagano, C., Massetti, E., and Rossi, C. (2011). New solid mucoadhesive systems for benzydamine vaginal administration, Colloids Surf. B Biointerfaces, 84, 413-420.
33. Garg, S., Goldman, D., Krumme, M., and Rohan, L. C., Smoot, S., and Friend, D. R. (2010). Advances in development, scale-up and manufacturing of microbicide gels, films, and tablets, Antiviral Res., 88 Suppl 1, S19-S29.
34. Malcolm, R. K., Edwards, K.-L., Kiser, P., Romano, J., and Smith, T. J. (2010). Advances in microbicide vaginal rings, Antiviral Res., 88, S30-S39.
35. Barnhart, K. T., Pretorius, E. S., Timbers, K., Shera, D., Shabbout, M., and Malamud, D. (2004). In vivo distribution of a vaginal gel: MRI evaluation of the effects of gel volume, time and simulated intercourse, Contraception, 70, 498-505.
36. Barnhart, K. T., Pretorius, E. S., Shaunik, A., Timbers, K., Nasution, M., and Mauck, C. (2005). Vaginal distribution of two volumes of the novel microbicide gel cellulose sulfate (2.5 and 3.5 mL), Contraception, 72, 65-70.
37. Rosen, R. K., Morrow, K. M., Carballo-Diéguez, A., Mantell, J. E., Hoffman, S., Gai, F., Maslankowski, L., El-Sadr, W. M., and Mayer K. H. (2008). Acceptability of tenofovir gel as a vaginal microbicide among women in a phase I trial: A mixed-methods study, J. Womens. Health (Larchmt.), 17, 383-392.
38. Nel, A. M., Mitchnick, L. B., Risha, P., Muungo, L. T., and Norick, P. M. (2011). Acceptability of vaginal film, soft-gel capsule, and tablet as potential microbicide delivery methods among African women, J. Womens. Health (Larchmt.), 20, 1207-1214.
39. Szeri, A. J., Park, S. C., Verguet, S., Weiss, A., and Katz, D. F. (2008). A model of transluminal flow of an anti-HIV microbicide vehicle:Combined elastic squeezing and gravitational sliding, Phys. Fluids (1994), 20, 83101.
40. Geonnotti, A. R., and Katz, D. F. (2010). Compartmental transport model of microbicide delivery by an intravaginal ring, J. Pharm. Sci., 99, 3514-3521.
41. Katz, D. F., and Dumire, E. N. (1993). Cervical mucus: Problems and opportunities for drug delivery via the vagina and cervix, Adv. Drug Deliv. Rev., 11, 385-401.
42. Schwartz, J. L., Rountree, W., Kashuba, A. D., Brache, V., Creinin, M. D., Poindexter, A., and Kearney, B. P. (2011). A multi-compartment, single and multiple dose pharmacokinetic study of the vaginal candidate microbicide 1% tenofovir gel, PLoS One, 6, e25974.
43. Hendrix, C. W., Chen, B. A., Guddera, V., Hoesley, C., Justman, J., Nakabiito, C., Salata, R., Soto-Torres, L., Patterson, K., Minnis, A. M., Gandham, S., Gomez, K., Richardson, B. A., and Bumpus, N. N. (2013). MTN-001:Randomized pharmacokinetic cross-over study comparing tenofovir vaginal gel and oral tablets in vaginal tissue and other compartments, PLoS One, 8, e55013.
44. Wang, Y., Qiao, W., Wang, B., Zhang, Y., Shao, P., and Yin, T. (2011). Electrospun composite nanofibers containing nanoparticles for the programmable release of dual drugs, Polym. J., 43, 478-483.
45. Su, Y., Su, Q., Liu, W., Lim, M., Venugopal, J. R., Mo, X., Ramakrishna, S., Al-Deyab, S. S., and El-Newehy, M. (2012). Controlled release of bone morphogenetic protein 2 and dexamethasone loaded in core-shell PLLACL-collagen fibers for use in bone tissue engineering, Acta Biomater., 8, 763-771.
46. Kim, T. G., Lee, D. S., and Park, T. G. (2007). Controlled protein release from electrospun biodegradable fiber mesh composed of poly(epsiloncaprolactone) and poly(ethylene oxide), Int. J. Pharm., 338, 276-283.
47. Luo, Y., Nartker, S., Miller, H., Hochhalter, D., Wiederoder, M., Wiederoder, S., Setterington, E., Drzal, L. T., and Alocilja, E. C. (2010). Surface functionalization of electrospun nanofibers for detecting E. coli O157:H7 and BVDV cells in a direct-charge transfer biosensor, Biosens. Bioelectron., 26, 1612-1617.
48. Jiang, H., Hu, Y., Li, Y., Zhao, P., Zhu, K., and Chen, W. (2005). A facile technique to prepare biodegradable coaxial electrospun nanofibers for controlled release of bioactive agents, J. Control. Release, 108, 237-243.
49. Yang, H., and Dong, L. (2010). Smart drug delivery using electrospun hollow nanofibers, 2010 IEEE 23rd International Conference on Micro Electro Mechanical Systems, 308-311.
50. Neurath, A. R., Strick, N., Jiang, S., Li, Y.-Y., and Debnath, A. K. (2010). Anti-HIV-1 activity of cellulose acetate phthalate: Synergy with soluble CD4 and induction of "dead-end" gp41 six-helix bundles, BMC Infect. Dis., 2, 6.
51. Ravel, J., Gajer, P., Abdo, Z., Schneider, G. M., Koenig, S. S., McCulle, S. L., Karlebach, S., Gorle, R., Russell, J., Tacket, C. O., Brotman, R. M., Davis, C. C., Ault, K., Peralta, L., and Forney, L. J. (2011). Vaginal microbiome of reproductive-age women, Proc. Natl. Acad. Sci. U. S. A., 108 Suppl 1, 4680-4687.
52. Kharsany, A. B., Hoosen, A. A., and Moodley, J. (1997). Bacterial vaginosis and lower genital tract infections in women attending out-patient clinics at a tertiary institution serving a developing community, J. Obstet. Gynaecol., 17, 171-175.
53. Li, Q., Estes, J. D., Schlievert, P. M., Duan, L., Brosnahan, A. J., Southern, P. J., Reilly, C. S., Peterson, M. L., Schultz-Darken, N., Brunner, K. G., Nephew, K. R., Pambuccian, S., Lifson, J. D., Carlis, J. V., and Haase, A. T. (2009). Glycerol monolaurate prevents mucosal SIV transmission, Nature, 458, 1034-1038.
54. Andrews, G. P., Donnelly, L., Jones, D. S., Curran, R. M., Morrow, R. J., Woolfson, A. D., and Malcolm, R. K. (2009). Characterization of the rheological, mucoadhesive, and drug release properties of highly structured gel platforms for intravaginal drug delivery, Biomacromolecules, 10, 2427-2435.
55. Forbes, C. J., Lowry, D., Geer, L., Veazey, R. S., Shattock, R. J., Klasse, P. J., Mitchnick, M., Goldman, L., Doyle, L. A., Muldoon, B. C., Woolfson, A. D., Moore, J. P., and Malcolm, R. K. (2011). Non-aqueous silicone elastomer gels as a vaginal microbicide delivery system for the HIV-1 entry inhibitor maraviroc, J. Control. Release, 156, 161-169.
56. Zeng, J., Yang, L., Liang, Q., Zhang, X., Guan, H., Xu, X., Chen, X., and Jing, X. (2005). Influence of the drug compatibility with polymer solution on the release kinetics of electrospun fiber formulation, J. Control. Release, 105, 43-51.
57. Cui, W., Li, X., Zhu, X., Yu, G., Zhou, S., and Weng, J. (2006). Investigation of drug release and matrix degradation of electrospun poly(DLlactide) fibers with paracetanol inoculation, Biomacromolecules, 7, 1623-1629.
58. Xie, J., and Wang, C.-H. (2006). Electrospun micro-and nanofibers for sustained delivery of paclitaxel to treat C6 glioma in vitro, Pharm. Res., 23, 1817-1826.
59. Baker, B. M., Nerurkar, N. L., Burdick, J. A., Elliott, D. M., and Mauck, R. L. (2009). Fabrication and modeling of dynamic multipolymer nanofibrous scaffolds, J. Biomech. Eng., 131, 101012.
60. Zeng, J., Aigner, A., Czubayko, F., Kissel, T., Wendorff, J. H., and Greiner, A. (2005). Poly(vinyl alcohol) nanofibers by electrospinning as a protein delivery system and the retardation of enzyme release by additional polymer coatings, Biomacromolecules, 6, 1484-1488.
61. Szentivanyi, A., Assmann, U., Schuster, R., and Glasmacher, B. (2009). Production of biohybrid protein/PEO scaffolds by electrospinning, Materialwiss. Werkst., 40, 65-72.
62. Malcolm, R. K., Veazey, R. S., Geer, L., Lowry, D., Fetherston, S. M., Murphy, D. J., Boyd, P., Major, I., Shattock, R. J., Klasse, P. J., Doyle, L. A., Rasmussen, K. K., Goldman, L., Ketas, T. J., and Moore, J. P. (2012). Sustained release of the CCR5 inhibitors CMPD167 and maraviroc from vaginal rings in rhesus macaques, Antimicrob. Agents Chemother., 56, 2251-2258.
63. Veazey, R. S., Ketas, T. J., Dufour, J., Moroney-Rasmussen, T., Green, L. C., Klasse, P. J., and Moore, J. P. (2010). Protection of rhesus macaques from vaginal infection by vaginally delivered maraviroc, an inhibitor of HIV-1 entry via the CCR5 co-receptor, J. Infect. Dis., 202, 739-744.
64. Yu, D. G., Yang, J. M., Branford-White, C., Lu, P., Zhang, L., Zhu, L. M. (2010). Third generation solid dispersions of ferulic acid in electrospun composite nanofibers, Int. J. Pharm., 400, 158-164.
65. Nuttall, J., Kashuba, A., Wang, R., White, N., Allen, P., Roberts, J., and Romano, J. (2012). Pharmacokinetics of tenofovir following intravaginal and intrarectal administration of tenofovir gel to rhesus macaques, Antimicrob. Agents Chemother., 56, 103-109.
66. Ndesendo, V. M., Pillay, V., Choonara, Y. E., Buchmann, E., Bayever, D. N., and Meyer, L. C. (2008). A review of current intravaginal drug delivery approaches employed for the prophylaxis of HIV/AIDS and prevention of sexually transmitted infections, AAPS PharmSciTech, 9, 505-520.
67. Mahalingam, A., Smith, E., Fabian, J., Damian, F. R., Peters, J. J., Clark, M. R., Friend, D. R., Katz, D. F., and Kiser, P. F. (2010). Design of a semisolid vaginal microbicide gel by relating composition to properties and performance, Pharm. Res., 27, 2478-2491.
68. Morrow, K. M., Rosen, R. K., Salomon, L., Woodsong, C., Severy, L., Fava, J. L., Vargas, S., and Barroso, C. (2011). Using integrated mixed methods to develop behavioral measures of factors associated with microbicide acceptability, Qual. Health Res., 21, 987-999.
69. Novák, A., la Loge, de, C., Abetz, L., and van der Meulen, E. A. (2003). The combined contraceptive vaginal ring, NuvaRing: An international study of user acceptability, Contraception, 67, 187-194.
70. Graessley, W. W. (1974). The entanglement concept in polymer rheology, Adv. Polym. Sci., 16, 1-179.
71. Stijnman, A. C., Bodnar, I., and Tromp, R. H. (2011). Electrospinning of food-grade polysaccharides, Food Hydrocolloids, 25, 1393-1398.
72. Hu, W., Huang, Z.-M., and Liu, X.-Y. (2010). Development of braided drug-loaded nanofiber sutures, Nanotechnology, 21, 315104.
73. Xie, J., Michael, P. L., Zhong, S., Ma, B., MacEwan, M. R., and Lim, C. T. (2012). Mussel inspired protein-mediated surface modification to electrospun fibers and their potential biomedical applications, J. Biomed. Mater. Res. A, 100A, 929-938.
74. Yohe, S. T., Colson, Y. L., and Grinstaff, M. W. (2012). Superhydrophobic materials for tunable drug release: Using displacement of air to control delivery rates, J. Am. Chem. Soc., 134, 2016-2019.
75. Wang, X., Ding, B., Yu, J., and Wang, M. (2011). Engineering biomimetic superhydrophobic surfaces of electrospun nanomaterials, Nano Today, 6, 510-530.
76. Yohe, S. T., Freedman, J. D., Falde, E. J., Colson, Y. L., and Grinstaff, M. W. (2013). A mechanistic study of wetting superhydrophobic porous 3D meshes, Adv. Funct. Mater., 23, 3628-3637.
77. Chen, H., Huang, J., Yu, J., Liu, S., and Gu, P. (2011). Electrospun chitosan-graft-poly (e-caprolactone)/poly (e-caprolactone) cationic nanofibrous mats as potential scaffolds for skin tissue engineering, Int. J. Biol. Macromol., 48, 13-19.
78. Tang, C., Ozcam, A. E., Stout, B., and Khan, S. A. (2012). Effect of pH on protein distribution in electrospun PVA/BSA composite nanofibers, Biomacromolecules, 13, 1269-1278.
79. Wang, M., Yu, J. H., Kaplan, D. L., and Rutledge, G. C. (2006). Production of submicron diameter silk fibers under benign processing conditions by two-fluid electrospinning, Macromolecules, 39, 1102-1107.
80. Garg, S., Kandarapu, R., Vermani, K., Tambwekar, K. R., Garg, A., Waller, D. P., and Zaneveld, L. J. (2003). Development pharmaceutics of microbicide formulations. Part I: Preformulation considerations and challenges, AIDS Patient Care STDS, 17, 17-32.
81. Garg, S., Tambwekar, K. R., Vermani, K., Kandarapu, R., Garg, A., Waller, D. P., and Zaneveld, L. J. (2003). Development pharmaceutics of microbicide formulations. Part II: Formulation, evaluation, and challenges, AIDS Patient Care STDS, 17, 377-399.
82. Luo, C. J., Stoyanov, S. D., Stride, E., Pelan, E., and Edirisinghe, M. (2012). Electrospinning versus fibre production methods: From specifics to technological convergence, Chem. Soc. Rev., 41, 4708-4735.
83. Theron, S. A., Zussman, E., and Yarin, A. L. (2004). Experimental investigation of the governing parameters in the electrospinning of polymer solutions, Polymer, 45, 2017-2030.
84. Varesano, A., Rombaldoni, F., Mazzuchetti, G., Tonin, C., and Comotto, R. (2010). Multi-jet nozzle electrospinning on textile substrates:Observations on process and nanofibre mat deposition, Polym. Int., 59, 1606-1615.
85. Persano, L., Camposeo, A., Tekmen, C., and Pisignano, D. (2013). Industrial upscaling of electrospinning and applications of polymer nanofibers: A review, Macromol. Mater. Eng., 298, 504-520.
86. Zhou, F.-L., Gong, R.-H., and Porat, I. (2009). Mass production of nanofibre assemblies by electrostatic spinning, Polym. Int., 58, 331-342.
87. Lukas, D., Sarkar, A., and Pokorny, P. (2008). Self-organization of jets in electrospinning from free liquid surface: A generalized approach, J. Appl. Phys., 103, 084309.
88. Forward, K. M., and Rutledge, G. C. (2012). Free surface electrospinning from a wire electrode, Chem. Eng. J., 183, 492-503.